ZHBIO: Calcium silicate bioceramic bone repair materials are expected to be approved within the year

On May 13th, ZHBIO stated during an institutional survey that the company continues to refine its product industrialization capabilities in research and development, striving for more new product approvals. In January of this year, the company's second-generation oral repair membrane was approved, and the calcium silicate bioceramic bone repair material is expected to be approved within the year, which will help enrich the company's product matrix in the oral field. Other products in the clinical stage mainly include intrauterine repair membranes and breast patches. The successive launch of these products will expand the company's downstream application departments to obstetrics and gynecology, breast surgery, and more